Clover Corporation Limited (ASX:CLV) has disclosed that 426,801 unquoted performance rights designated CLVAS have ceased following the lapse of conditional rights, with the company confirming the FY24 Performance Rights were 50% vested and 50% lapsed as at 31 July 2026.
Key Points
- 426,801 CLVAS Performance Rights ceased on 31 July 2026 due to conditions not being met or becoming incapable of being satisfied
- The FY24 Performance Rights were 50% vested and 50% lapsed, according to the filing
- No consideration was paid by the company for the cessation of the securities
- Following the cessation, 2,837,366 CLVAS Performance Rights remain on issue as unquoted equity securities
- Clover Corporation's total quoted ordinary fully paid shares on issue stand at 166,999,341
Performance Rights Cessation Details
According to the filing lodged on 18 November 2026, the 426,801 CLVAS Performance Rights ceased on 31 July 2026. The stated reason for cessation is the lapse of a conditional right to securities because the conditions have not been, or have become incapable of being, satisfied. The filing identifies these as FY24 Performance Rights. Clover Corporation confirmed it did not pay any consideration in connection with the cessation of these securities. The notification was submitted as a new announcement under Appendix 3H of ASX listing rules.
Partial Vesting of FY24 Performance Rights
Clover Corporation disclosed in the filing that the FY24 Performance Rights were subject to a split outcome, with 50% of the rights vesting and 50% lapsing. The 426,801 securities reported as ceased represent the lapsed portion of this tranche. The filing does not provide further details regarding the specific performance conditions attached to the rights or the basis upon which the partial vesting determination was made. No additional commentary was provided by the company regarding the outcome.
Issued Capital Following the Cessation
Following the cessation of the 426,801 performance rights, Clover Corporation's issued capital comprises 166,999,341 CLV ordinary fully paid shares on a quoted basis, and 2,837,366 CLVAS Performance Rights remaining as unquoted equity securities. The filing notes that the figures presented in the issued capital tables are automatically generated and may not reflect the entity's current issued capital if other Appendix forms are currently being processed by ASX at the time of this notification.



Please wait processing your request...